Astellas Pharma (16 long-listed products) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Astellas Pharma (16 long-listed products) General Information

Description

A pharmaceutical products developer in Tokyo, Japan. The pharmaceutical products include 16 long-listed products made from pharmaceutical drugs.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Tokyo
  • Japan
Primary Industry
Buildings and Property
Other Industries
Drug Discovery
Acquirer
Corporate Office
  • Tokyo
  • Japan

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Astellas Pharma (16 long-listed products) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Astellas Pharma (16 long-listed products)‘s full profile, request access.

Request a free trial

Astellas Pharma (16 long-listed products) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Astellas Pharma (16 long-listed products)‘s full profile, request access.

Request a free trial

Astellas Pharma (16 long-listed products) FAQs

  • Where is Astellas Pharma (16 long-listed products) headquartered?

    Astellas Pharma (16 long-listed products) is headquartered in Tokyo, Japan.

  • What industry is Astellas Pharma (16 long-listed products) in?

    Astellas Pharma (16 long-listed products)’s primary industry is Buildings and Property.

  • Is Astellas Pharma (16 long-listed products) a private or public company?

    Astellas Pharma (16 long-listed products) is a Private company.

  • What is the current valuation of Astellas Pharma (16 long-listed products)?

    The current valuation of Astellas Pharma (16 long-listed products) is .

  • What is Astellas Pharma (16 long-listed products)’s current revenue?

    The current revenue for Astellas Pharma (16 long-listed products) is .

  • Who are Astellas Pharma (16 long-listed products)’s investors?

    Astellas Pharma has invested in Astellas Pharma (16 long-listed products).

  • When was Astellas Pharma (16 long-listed products) acquired?

    Astellas Pharma (16 long-listed products) was acquired on 28-Apr-2017.

  • Who acquired Astellas Pharma (16 long-listed products)?

    Astellas Pharma (16 long-listed products) was acquired by LTL Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process